Belite Bio (BLTE)
(Delayed Data from NSDQ)
$66.31 USD
-3.48 (-4.99%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $66.70 +0.39 (0.59%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth F Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Belite Bio, Inc. Sponsored ADR has a market cap of $2.22B, which represents its share price of $69.79 multiplied by its outstanding shares number of 31.84M. As a mid-cap company, BLTE's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
BLTE 66.31 -3.48(-4.99%)
Will BLTE be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BLTE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BLTE
New Strong Sell Stocks for August 4th
New Strong Sell Stocks for July 22nd
BLTE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for BLTE
Belite Bio to Host Webcast on August 11, 2025, to Discuss Second Quarter 2025 Financial Results ...
Belite Bio Inc (BLTE) Announces Upcoming Webcast for Q2 2025 Financial Results | BLTE stock news
Belite Bio to Participate in the BTIG Virtual Biotechnology Conference | BLTE Stock News
Belite Bio Inc (BLTE) to Participate in BTIG Virtual Biotechnology Conference | BLTE stock news
Bullish Two Hundred Day Moving Average Cross - BLTE